ECHS1 and Leigh syndrome: Pharmacological manipulation of mTOR might alleviate the metabolic effects of ECHS1‐deficiency paralleling the results obtained in other genetic forms of mitochondrial‐related neurodegeneration,19 including Leigh Syndrome.20